- Article metrics
- Last updated: Thu, 25 Apr 2024 21:01:27 Z
MP470, a novel receptor tyrosine kinase inhibitor, in combination with Erlotinib inhibits the HER family/PI3K/Akt pathway and tumor growth in prostate cancer
Access & Citations
-
- 7392
- Article Accesses
-
- 39
- CrossRef
Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.